BioPortUSA has signed a new partnership agreement with Seijgraaf BV, one of Hollands leading life science consultancies. Ron de Graaf, founder of Seijgraaf has over 36 years of experience working with over 600 health tech companies ranging in size from the Philips organization to start-ups. “His wealth and knowledge of the Dutch and European Healthcare Market will be invaluable to US clients of ours wishing to cross the pond” stated Mark Lesselroth, CEO of BioPortUSA. “We have been looking for a partner who has the ability to provide access to all necessary services required to be successful in the U.S. healthcare market” stated Ron De Graaff.
Over the coming weeks and months, both organizations will focus on identifying opportunities to collaborate with one another by organizing speaking engagements and making mutual introductions to prospective clients.
In his career, Mr. de Graff has advised more than 600 private and public sector health care providers, insurers and manufacturers of pharmaceuticals and medical devices, giving advice mainly in the field of strategy and policy structures, related to and resulting from the finance structures of the Dutch healthcare system totalling more than 2,500 projects.